| Bioactivity | VU6028418 is a potent, highly selective and orally bioavailable M4 mAChR antagonist with an IC50 of 4.1 nM against hM4[1]. | ||||||||||||
| In Vivo | VU6028418 is orally bioavailable[1].In Vivo PK Parameters for VU6028418[1] parameter | ||||||||||||
| Name | VU6028418 | ||||||||||||
| CAS | 2649803-05-2 | ||||||||||||
| Formula | C23H27F3N4O | ||||||||||||
| Molar Mass | 432.48 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Spock M, et al. Discovery of VU6028418: A Highly Selective and Orally Bioavailable M4 Muscarinic Acetylcholine Receptor Antagonist. ACS Med Chem Lett. 2021 Aug 2;12(8):1342-1349. |